Nutrition and lifestyle in patients pharmacologically treated due to hypertension by Jarosz, Mirosław et al.
Address for correspondence: Prof. Mirosław Jarosz, MD, PhD, Department of Nutrition and Dietetic with Clinic of Metabolic 
Diseases and Gastroenterology, National Food and Nutrition Institute, ul. Powsińska 61/63, 02–903 Warszawa, Poland,  
tel: +48 22 550-96-77, fax: +48 22 842-11-03, e-mail: jarosz@izz.waw.pl
Received: 16.12.2015 Accepted: 07.05.2016
Nutrition and lifestyle in patients  
pharmacologically treated due to hypertension
Mirosław Jarosz1, Diana Wolańska2, Hanna Stolińska1,  
Wioleta Respondek1, Longina Kłosiewicz-Latoszek2
1Department of Nutrition and Dietetics with Clinic of Metabolic Diseases and Gastroenterology,  
National Food and Nutrition Institute, Warsaw, Poland 
2Department of Prevention of Diet-related Diseases with Outpatient Clinic of Metabolic Diseases,  
National Food and Nutrition Institute, Warsaw, Poland
Abstract
Background: Proper nutrition and physical activity are together an important way of non-
-pharmacological treatment of arterial hypertension. The aim of the study was to answer the 
question whether patients with hypertension use non-pharmacological methods of hypertension 
treatment.
Methods: The study included a group of 280 patients aged 18–85, suffering from hyperten-
sion. In the study, 10 nutritional and non-nutritional factors affecting the treatment of hyper-
tension were analyzed. Data regarding the diet were collected by a method of 24-h recall. Basic 
anthropometric measurements (body weight, body height, waist and hip circumference) were 
taken, as well as threefold measurement of blood pressure. The data were statistically analyzed.
Results: The average value of blood pressure was 131.2 ± 15.5/82.9 ± 10.5 mm Hg. Ap-
proximately 90% of the respondents had abnormal body weight, i.e. excessive weight or obesity. 
Abdominal obesity according to waist hip ratio assessment was diagnosed in 87% of women 
and 66% of men; according to the measurement of waist circumference, it was diagnosed in 
140 (81%) women and 88 (81%) men. Among the ingredients with antihypertensive effect, the 
sodium intake was 4,417.8 ± 2,052.7 mg/d, which when converted to salt is on average 11 g/d, 
potassium: 3,808.5 ± 1,265.7 mg/d, calcium: 724.6 ± 413.7 mg/d, and magnesium: 383.9 ±  
± 139.3 mg/d. One in 5 (18%) people declared smoking. Only 5% of subjects reported high 
level of physical activity.
Conclusions: In persons with diagnosed hypertension, vast majority of patients did not imple-
ment non-pharmacological hypertension treatment. (Cardiol J 2016; 23, 5: 491–496)
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Introduction
Hypertension has been a serious medical 
problem for many years. It is estimated that the 
frequency of the prevalence of hypertension in the 
general population is approx. 30–45%, but it signifi-
cantly increases with age [1]. In the NATPOL study 
conducted in 2011, it was demonstrated that the 
number of people suffering from hypertension in-
creased during the last 10 years by 2% on average, 
and currently approx. 32% of adult Poles suffers 
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aged 18–79 and almost 1 million patients above 80) 
[2, 3]. In the WOBASZ study, the frequency of the 
prevalence of hypertension was 36%, including 
33% in women and 42% in men. In POLSENIOR 
study, the prevalence of hypertension in the sample 
of Poles (n = 4,929) over 64 years was 76% (72% 
in men, 78% in women) [4].
Hypertension is a major risk factor for cardio-
vascular disease, which in turn is the leading cause 
of death in industrialized countries. Hypertension 
very often co-occurs with obesity, diabetes, and 
lipid abnormalities, which greatly increases the risk 
of cardiovascular diseases. It is the leading cause 
of heart attacks and strokes, as well as heart and 
kidney failure.
It has been demonstrated that a properly 
conditioned modification of lifestyle has equivalent 
antihypertensive effect as the use of 1 antihyper-
tensive medicine [5]. The changes in lifestyle also 
contribute to the control of other cardiovascular 
risk factors resulting from the co-occurrence of 
diet-related diseases. The main recommended 
lifestyle changes that affect blood pressure (BP) 
include: reducing salt intake and alcohol consump-
tion, high intake of fruit, vegetables and calcium 
and diet consisting of low-fat products, especially of 
animal origin, maintaining appropriate body weight 
or its reduction in case of excessive weight/obesity, 
regular physical activity, smoking cessation [1].
Hypertension and its complications (e.g. 
strokes, heart attacks) are a serious public health 
problem and economic burden to the Polish health 
care system. In order to reduce the risk of compli-
cations and costs, non-pharmacological methods of 
hypertension treatment are important. Therefore, 
the authors decided to analyze whether patients 
with hypertension follow (and to what extent) the 
essential recommendations of non-pharmacological 
treatment of this disease.
The aim of the study was to answer the ques-
tion whether patients with hypertension use 
non-pharmacological methods of hypertension 
treatment.
Methods
The study was conducted at the National 
Food and Nutrition Institute from October 2010 
to November 2011 in a group of 280 subjects aged 
18–85. The study included patients referred to 
the Outpatient Clinic of Metabolic Diseases and 
Clinic of Metabolic Diseases and Gastroenterol-
ogy of the National Food and Nutrition Institute 
with diagnosed hypertension and who took an-
tihypertensive medicines on a permanent basis. 
The respondents gave their written consent to 
participate in the study.
In the study group, on the basis of the author’s 
questionnaire, data were collected  on the preva-
lence of diseases including hypertension, and type 
of pharmacotherapy chosen as treatment. Data on 
lifestyle factors that affect BP, including physical 
activity and smoking and alcohol consumption. Data 
on nutritional habits were collected by 24-h recall, 
on the basis of which the daily food ration was esti-
mated using the “Album of photos of products and 
dishes” [6] and its nutritional value was calculated 
using a computer program Diet 5.0.
In the study, 10 nutritional and non-nutritional 
factors, which affect the hypertension treatment 
were analyzed: intake of sodium, potassium, calci-
um, magnesium, adding salt to meals, drugs, intake 
of alcohol and smoking, prevalence of excessive 
weight and obesity, as well as physical activity. The 
level of physical activity was evaluated according to 
the following criteria: 1) Low physical activity — it 
refers to a person whose daily activities require no 
effort. The person moves mainly by car, and does 
not practice any sport regularly. The person spends 
most of the time sitting or standing. 2) Moderate 
physical activity — a person who has sedentary 
work, but regularly spends a certain amount of 
time on moderate or intensive physical activity. 
3) High physical activity — a person performing 
intense physical work regularly, a few hours a day.
Every subject had threefold BP measurement 
according to standard guidelines of the European 
Society of Hypertension (ESH) with the use of 
Omron MT-10 IT (Omron, Hoofddorp, The Neth-
erlands). From the obtained values, the average 
value of BP was calculated [7].
On the basis of anthropometric measurements 
(body weight and height), the nutritional status 
was assessed using weight-height body mass index 
(BMI), calculated according to the formula: BMI = 
body weight (kg) / body height (m2). According to 
World Health Organization (WHO) guidelines [8], 
excessive weight was recognized at BMI values 
25–29.9 kg/m2 and obesity when BMI was ≥ 30 kg/ 
/m2 [8]. Using the measurements of waist and hip 
circumference, waist hip ratio (WHR) was calculat-
ed defining the type of obesity. According to WHO 
guidelines it was assumed that the WHR value 
lower than 0.8 in women and lower than 1.0 in men 
indicates gynoid obesity (gluteal-femoral), whereas 
the WHR value higher than 0.8 in women and 
higher than 1.0 in men is determined as abdominal 
obesity. Abdominal obesity was also evaluated on 
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the basis of waist circumference measurement and 
the criteria adopted for the diagnosis of this anom-
aly according to National Cholesterol Education 
Program Adult Treatment Panel III (NCEP-ATP III) 
— waist circumference ≥ 102 cm in men and 
≥ 88 cm in non-pregnant women [9] The data were 
statistically analyzed using Statistica 10.0 program.
Results
Characteristics of the study group
The study group consisted of 280 patients, 
including 171 women and 109 men, respectively 
61% and 39% of the study group. The average 
age was 55.0 ± 12.1 years. The subjects were of 
secondary education (47%) and higher education 
(35%). Most patients (73%) were individuals who 
retired/retired or performed a sedentary job. Work 
requiring physical effort was 26% of respondents.
All subjects who participated in the study 
(n = 280) suffered from hypertension and took 
antihypertensive medicines on a permanent ba-
sis. These were mainly beta-blockers — 36% of 
respondents, comparable drugs from the group of 
angiotensin-converting enzyme (ACE) inhibitors 
and diuretics (22% and 20%), medicines in the 
angiotensin II receptor antagonists in 12% of pa-
tients, medicines calcium channel blockers — 10% 
of patients. Taking medicines for hypertension 
lasted for a period of 11.3 ± 8.7 years on average. 
The average value of BP in the whole group was 
131.2 ± 15.5/82.9 ± 10.5 mm Hg. Normal values 
of BP were encountered in 20% of respondents. 
Additional diseases were lipid disorders in 78% of 
patients, type II diabetes in 14%, and gout in 12%.
The results of anthropometric test
Average body weight was 96.5 ± 22.8 kg (89.9 ± 
± 21.3 kg for women and 107 ± 21.3 kg for men), 
BMI 34.0 ± 6.8 kg/m2. Ninety percent of respond-
ents had abnormal body weight, i.e. excessive 
weight or obesity. In 1 in 5 (19%) subjects, exces-
sive weight was diagnosed, i.e. BMI 25.0–29.9 kg/m2 
and in 71% it was obesity (BMI ≥ 30 kg/m2) includ-
ing morbid obesity (BMI > 40.0 kg/m2) which was 
diagnosed in 18% of people.
On the basis of WHR, it has been demon-
strated that among the subjects abdominal obesity 
prevailed. Average value of WHR was 0.87 ± 0.06 
in women and 1.02 ± 0.06 in men, respectively. The 
problem of abdominal obesity according to WHR 
evaluation concerned 87% of women and 66% of men.
Abdominal obesity, classified on the basis of 
waist circumference above 88 cm in women, was 
observed in 140 women (81%), and the average 
waist circumference was 104.7 ± 15.9 cm. Waist 
circumference above 102 cm, which is the evidence 
of abdominal obesity, was observed in 88 (81%) 
men and the average value was 116.3 ± 15.0 cm.
In addition to hypertension, 78% of the sub-
jects had lipid abnormalities (increased choles-
terol and triglycerides), 18% type II diabetes, 
and 13% gout.
Nutritional factors
The energy value of the analyzed daily food 
rations was on average 2146.9 ± 844.4 kcal. In the 
total pool of energy, energy from protein constitut-
ed 18.2 ± 4.9%, from carbohydrates 47.7 ± 8.9%, 
and from fat 33.3 ± 8.4%. Protein intake averagely 
amounted to 94.4 ± 37.1 g, including 65.6 ± 31.1 g 
of protein of animal origin and 28.7 ± 11.2 g of veg-
etable protein. Average protein intake per kg body 
weight was 1 g. Among the ingredients with anti-
hypertensive effect, sodium intake was 4,417.8 ± 
± 2,052.7 mg/d, which when converted to salt was on 
average 11 g/d, potassium: 3,808.5 ± 1,265.7 mg/d, 
calcium: 724.6 ± 413.7 mg/d and magnesium: 
383.9 ± 139.3 mg/d. Every third (30%) person in 
the study group added salt to ready-made meals, 
and the most commonly used salt was ordinary, 
iodized salt (55%) or rock (29%) salt. Only 9% 
of respondents chose low sodium, potassium or 
magnesium salt.
Lifestyle factors
Only 5% of patients declared high level of 
physical activity and 41% of respondents declared 
moderate level of physical activity. In contrast, 
low level of physical activity was declared by more 
than half of the respondents (53%). The most often 
chosen form of activity was walking — 40% of the 
respondents.
Among the subjects, 1 in 5 (18%) person de-
clared smoking. These were subjects who, despite 
diagnosed disease, did not refrain from smoking, 
they smoked on average for 21.9 ± 12.2 years, 
15.4 ± 7.2 cigarettes per day.
In the analysis assessing the implementation 
of the recommendations of non-pharmacological 
hypertension treatment (Table 1) [10], the intake 
of too high amount of sodium and low intake of 
potassium, calcium and magnesium with the diet 
was observed. In the study group, high percent-
age of the participants had abnormal body weight, 
especially abdominal obesity.
Regular alcohol consumption (at least 2–3 
times a week) was declared by 17% of people. 
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They were mostly men — 86% of respondents. The 
most popular drink was beer  — 60% of subjects 
who consume alcohol regularly, and wine — 34% 
of respondents. The others (83%) drank alcohol 
occasionally (not more than 1–2 times a month or 
less), or did not consume alcohol at all.
Discussion
The scientific literature, both domestic and 
foreign, does not include analyses concerning the 
application of the recommendations of a healthy 
lifestyle (nutrition and physical activity) by persons 
with diagnosed hypertension. Only the analyses 
discussing the impact of individual elements of 
lifestyle, including diet, on BP are available.
In the analysis of own research it was dem-
onstrated that every fifth person had excessive 
weight and 71% had obesity, including morbid 
obesity in 18% of people.
The problem of abdominal obesity, according 
to WHR evaluation, concerned 87% of women and 
66% of men, while according to waist circumfer-
ence criterion it occurred in 140 (81%) women and 
88 (81%) men. Such a high percentage of people 
with abnormal body weight, especially abdominal 
obesity, is one of the most important factors affect-
ing the development of hypertension.
The findings of the studies suggest that body 
weight reduction is conducive to lowering BP. 
A meta-analysis of 25 studies showed an average 
reduction of systolic BP (SBP) and diastolic BP 
(DBP) by 4.4 and 3.6 mm Hg with each 5 kg of 
body weight loss [11].
In the analysis of the Korea National Health 
and Nutrition Examination Survey, it was demon-
strated that individuals with sarcopenic obesity 
(loss of muscle tissue and the excessive growth 
of body fat) have approx. 12 mm Hg higher SBP 
and 5 mm higher Hg DBP than people with simple 
obesity [12].
In the studies by Despres at al. [13], evaluat-
ing the relationship between the content of body 
fat and the values of BP, it was observed that 
the amount of subcutaneous fat and its percent-
age content is significantly correlated with DBP 
(r = 0.37, p < 0.0005) and SBP (r = 0.29, p < 0.01). 
Other factors contributing to BP were age and, in 
men, alcohol consumption.
In our study, lack of physical activity or its low 
level was declared by 53% of respondents, and only 
5% declared high level of physical activity.
In a recent meta-analysis of randomized con-
trolled clinical trials, it was concluded that dynamic, 
aerobic endurance training reduces SBP and DBP 
at rest by 3.0/2.4 mm Hg and the average pres-
sure throughout the day in ambulatory monitoring 
by 3.3/35 mm Hg. The reduction of SBP at rest 
was higher in patients with hypertension (–6.9/ 
/–4.9 mm Hg) than in patients with normal BP 
Table 1. Implementation of the recommendations of nutritional and lifestyle factors that affect blood 
pressure among people with hypertension.
Modifiable nutritional  




The number and proportion  
of the study population (n = 280)
Achieved  
desirable values (n/%)
Lack of achieved  
desirable values (n/%)
Nourishment:        
Sodium < 1500 mg* 9 3 271 97
Potassium > 4700 mg* 57 20 223 80
Calcium > 1000 mg* 56 20 224 80
Magnesium > 320 mg/420 mg* 147 53 133 47
Adding salt to meals No 196 70 84 30
Smoking No 231 82 49 18
Alcohol consumption No 233 83 47 17
Excessive weight and obesity BMI < 25 kg/m2 29 10 251 90
Abdominal obesity WHR: women < 0.8, 
men: < 1.0
49 17 231 83
Physical activity Moderate and high 130 46 150 54
Data are presented as numbers and percentages; BMI — body mass index, WHR — waist to hip ratio; *Jarosz M. ed., 2012 [10]
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(–1.9/–1.6 mm Hg). Even moderate physical activ-
ity lowered BP [14].
Among the study group, every fifth (18%) 
person declared smoking. These were the subjects 
who, despite the diagnosed disease, did not refrain 
from smoking, and smoked on average for 21.9 ± 
± 12.2 years, 15.4 ± 7.2 cigarettes per day.
Wanshu et al. [15], while evaluating 27,789 vol-
unteers of the Chinese population, demonstrated 
that the common prevalence of excessive weight 
and smoking causes a 4.49 times greater risk of 
hypertension than a single factor [15].
In the 7-year study (2003–2010), where 297 
healthy adults were observed, it was shown that 
over this time the main reason for the develop-
ment of hypertension in 23.6% of subjects was the 
prevalence of abdominal obesity and smoking [16].
In another study, the strength of the main risk 
factors of the development of  hypertension was 
determined — origin, nutritional habits, alcohol 
consumption, smoking, stress level and medical 
history. It has been demonstrated that among 
women high BP was significantly dependent on the 
age (U = 10,513.5; z = –5.117), BMI (U = 9,635; 
z = –5.832), WHR (U = 12,738; z = –2.888) and 
level of cholesterol (U = 2,827.5; z = –2268). 
Among men, the significant factors involved in the 
development of hypertension were age, BMI, and 
stress level [17].
In our study, among the antihypertensive 
ingredients, the sodium intake was 4,417 ± 2,052 
mg/d, which when converted to salt constituted 
on average 11.0 g/d, potassium: 3,808.5 ± 1,265.7 
mg/d, calcium: 724.6 ± 413.7 mg/d, and magne-
sium: 383.9 ± 139.3 mg/d.
In recommendations concerning salt intake, 
the amount not more than 5–6 g per day is deter-
mined, while the average intake in many countries 
is approx. 9–12 g per day. In the Joint National Com-
mittee (JNC) report, it is recommended for patients 
with hypertension to limit the sodium intake to 
2.4 g (6 g NaCl) per day [18]. In our study, it 
amounted to 11 g/d. The percentage of people 
consuming salt in an amount above 6 g/d was 97%.
The reduction of salt intake to approx. 5 g per 
day contributes to lowering BP by 4–5 mm Hg in 
hypertensive persons and about 1–2 mm Hg in 
normotensive persons [19]. In a landmark study, 
the International Study of Salt and Blood Pres-
sure (INTERSALT) international research project 
involving more than 10,000 people aged 20–59 
from 32 countries — it was demonstrated that the 
difference in sodium intake of 100 mmol per day 
(6 g NaCl) is associated with the difference of SBP/ 
/DBP of 6/3 mm Hg [20].
The consumption of excessive amounts of 
sodium chloride contributes to the increase of BP, 
and leads to a variety of metabolic disorders, among 
others, the weakening of nitric oxide synthetase 
activity and the reduction of insulin sensitivity [21]. 
While analyzing the role of sodium in the etiology 
of hypertension it has been demonstrated that its 
reduced intake, especially when combined with the 
application of Dietary Approach to Stop Hyperten-
sion (DASH) diet, has a beneficial effect on BP and 
lipid metabolism, both in healthy individuals as well 
as in persons with hypertension [22].
In the meta-analysis of studies assessing the 
impact of the diet low in sodium on BP, it has been 
shown that in adults the reduction of sodium intake 
contributes to lowering systolic BP by 3.39 mm Hg 
(95%, 2.46–4.31) and diastolic BP by 1.54 mm Hg 
(0.98–2.11). Sodium intake of less than 2 g per day 
is conducive to lowering systolic BP by 3.47 mm Hg 
(0.76–6.18) and diastolic BP by 1.81 mm Hg 
(0.54–3.08) [23].
A diet that includes natural sources of po-
tassium is important in controlling BP because 
potassium reduces the effects of sodium. The 
recommended daily intake of potassium for an 
average adult is about 4,700 mg/day [10]. Potas-
sium supplementation increases the production 
of nitric oxide in the endothelium and relieves 
the organ effects of hypertension. It has been ob-
served, however, that in animals, too large intake 
of sodium and potassium led to cardiac hypertrophy 
and stroke [24].
There are no precise data defining the dose 
of potassium as an agent lowering BP. However, 
the consumption of at least 4.7 g (120 mmol/day) 
demonstrates a very good therapeutic effect. The 
meta-analysis of Whelton et al. [25] showed that 
the increase of potassium intake lowers BP both in 
patients with and without hypertension. In another 
meta-analysis, it was demonstrated that increased 
potassium intake leads to lowering of the SBP by 
3.49 mm Hg (95% CI 1.82–5.15) [26].
The influence of calcium and magnesium 
on BP is ambiguous and not fully understood. 
It is believed that the impact of calcium on BP 
is associated with its effect on vascular smooth 
muscles, Ca-dependent hormones (PTH, 1.25 
dihydroxyvitamin D3, calcitonin) activity of renin–
angiotensin system, the activity of the sympathetic 
nervous system, metabolism of other electrolytes, 
calcium-binding proteins, and the concentration 
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of free intracellular calcium, whereas the role 
of other elements in the regulation of BP value 
may be largely linked to their influence on cal-
cium metabolism [27]. In the studies, an inverse 
relationship between the content of potassium, 
calcium and magnesium in the diet and the BP 
value is observed [28, 29]. Meta-analyses show 
a small reduction of SBP from 0.9 to 1.4 mm Hg 
and DBP from 0.2 to 0.8 mm Hg during calcium 
supplementation (400–2,000 mg/d) [30].
Conclusions
In summary, in patients with diagnosed hy-
pertension, vast majority of patients have not 
implemented non-pharmacological methods of 
hypertension treatment. The most important fac-
tors were: excessive weight, including abdominal 
obesity, low or lack of physical activity, incorrect 
nutrition (low calcium and potassium intake). High 
(97%) percentage of people who consume exces-
sive amounts of salt has been demonstrated, which 
is one of the main factors in the development of 
hypertension. In the healthcare system, there is 
an urgent need to develop effective methods of 
education of patients with hypertension. An essen-
tial element that would improve the effectiveness 
of hypertension treatment would be individual 
work with a nutritionist on the introduction and 
implementation of non-pharmacological methods 
of treatment of this disease.
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